Literature DB >> 25922180

Development and validation of a novel assay to identify radiosensitizers that target nucleophosmin 1.

Narsimha R Penthala1, Peter A Crooks1, Michael L Freeman2, Konjeti R Sekhar3.   

Abstract

A series of indole analogs that are synthesized using the scaffold of a potent radiosensitizer, YTR107, were tested for their ability to alter the solubility of phosphorylated nucleophosmin 1 (pNPM1). NPM1 is critical for DNA double strand break (DSB) repair. In response to formation of DNA DSBs, phosphorylated T199 NPM1 binds to ubiquitinated chromatin, in a RNF8/RNF168-dependent manner, forming irradiation-induced foci (IRIF) that promote repair of DNA DSBs. A Western blot assay was developed using lead molecule, YTR107, for the purpose of screening newly synthesized molecules that target pNPM1 in irradiated cells. A colony formation assay was used to demonstrate the radiosensitization properties of the compounds. Compounds that enhanced the extractability of pNPM1 upon radiation treatment possessed radiosensitization properties.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Assay development; Cancer; DNA repair; Indole analogs; Lung cancer; NPM1; Nucleophosmin 1; PNR605; Radiation; Radiosensitizers; YTR107

Mesh:

Substances:

Year:  2015        PMID: 25922180      PMCID: PMC4418231          DOI: 10.1016/j.bmc.2015.04.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  17 in total

1.  Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing.

Authors:  Pheruza Tarapore; Kazuya Shinmura; Hitoshi Suzuki; Yukari Tokuyama; Song-Hee Kim; Akila Mayeda; Kenji Fukasawa
Journal:  FEBS Lett       Date:  2005-12-19       Impact factor: 4.124

Review 2.  Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?

Authors:  Amit R Patel; Andrew J Stephenson
Journal:  Nat Rev Urol       Date:  2011-06-14       Impact factor: 14.432

3.  Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23.

Authors:  Sandeep S Negi; Mark O J Olson
Journal:  J Cell Sci       Date:  2006-08-15       Impact factor: 5.285

4.  Role of nucleophosmin in embryonic development and tumorigenesis.

Authors:  Silvia Grisendi; Rosa Bernardi; Marco Rossi; Ke Cheng; Luipa Khandker; Katia Manova; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-07-06       Impact factor: 49.962

5.  Examination for a correlation between probabilities of development of distant metastasis and of local recurrence.

Authors:  H D Suit; R S Sedlacek; E L Gillette
Journal:  Radiology       Date:  1970-04       Impact factor: 11.105

6.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

7.  Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates.

Authors:  Ayaka Koike; Hiroyuki Nishikawa; Wenwen Wu; Yukinori Okada; Ashok R Venkitaraman; Tomohiko Ohta
Journal:  Cancer Res       Date:  2010-08-16       Impact factor: 12.701

8.  Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase.

Authors:  C M Bradbury; S Markovina; S J Wei; L M Rene; I Zoberi; N Horikoshi; D Gius
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

9.  Novel substituted (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-diones and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones as potent radio-sensitizing agents.

Authors:  Y Thirupathi Reddy; Konjeti R Sekhar; Nidhish Sasi; P Narsimha Reddy; Michael L Freeman; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2009-11-22       Impact factor: 2.823

Review 10.  NF-kappa B-mediated adaptive resistance to ionizing radiation.

Authors:  Kazi Mokim Ahmed; Jian Jian Li
Journal:  Free Radic Biol Med       Date:  2007-10-10       Impact factor: 7.376

View more
  3 in total

1.  1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).

Authors:  Narsimha Reddy Penthala; Amit Ketkar; Konjeti R Sekhar; Michael L Freeman; Robert L Eoff; Ramesh Balusu; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2015-11-15       Impact factor: 3.641

2.  Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC.

Authors:  Geri Traver; Konjeti R Sekhar; Peter A Crooks; Diane S Keeney; Michael L Freeman
Journal:  Cancer Lett       Date:  2020-12-21       Impact factor: 8.679

3.  Phosphoproteome Profiling Reveals Multifunctional Protein NPM1 as part of the Irradiation Response of Tumor Cells.

Authors:  Nadine Wiesmann; Rita Gieringer; Franz Grus; Juergen Brieger
Journal:  Transl Oncol       Date:  2018-11-16       Impact factor: 4.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.